Recently, the presence of deleted forms of the HTLV-I provirus was described in 6 out of 6 cases of CTCL. We investigated whether the presence of these viral genomes could be verified in 20 patients with CTCL using the polymerase chain reaction (PCR) and Southern blot analysis. Only one of the 20 cases showed a band corresponding to the pX region of HTLV-I. These data indicate that in the majority of CTCL cases, sequences closely related to HTLV-I are not present, or their copy number is below the limit of detection employed in this study.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
rs179008 (A/T) and rs3853839 (C/G) polymorphisms are associated with variations in IFN-α levels in HTLV-1 infection.
Front Immunol
December 2024
Laboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Brazil.
Article Synopsis
- The study investigates how genetic variations in the TLR7 gene impact responses to HTLV-1 infection, focusing on cytokine production and disease symptoms.
- Researchers analyzed blood samples from HTLV-1 infected individuals, including those with inflammatory diseases and asymptomatic cases, alongside controls, using techniques like PCR and ELISA.
- Findings indicated that specific genetic variations (polymorphisms) affect levels of immune responses, with some variants linked to higher levels of antiviral activity, though they did not correlate with disease symptoms.
First report on human T-lymphotropic virus 1 infection in a group of transgender women.
Front Public Health
November 2024
Institute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia, Brazil.
Article Synopsis
- A study was conducted to determine the prevalence of HTLV-1 infection among transgender women (TGW) in Goiânia City, Brazil, revealing a knowledge gap in existing data on this demographic.
- From a sample of 235 TGW, 1.3% tested positive for HTLV-1, with those positive reporting high-risk sexual behaviors and drug use.
- The findings highlight the urgent need for health programs aimed at TGW to control HTLV-1 and other sexually transmitted infections due to their high-risk behaviors.
Antiviral immune response against HTLV-1 invalidates T-SPOT.TB results in patients with HTLV-1-positive rheumatic diseases.
Front Immunol
November 2024
Division of Respirology, Rheumatology, Infectious Diseases and Neurology, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan.
Background: T-SPOT.TB, one of the screening tests for latent tuberculosis infection (LTBI), yields invalid results in human T-cell leukemia virus type 1 (HTLV-1)-positive patients with rheumatoid arthritis. However, the detailed mechanisms behind this invalidation are unclear.
View Article and Find Full Text PDFHTLV-1 infected T cells cause bone loss via small extracellular vesicles.
J Extracell Vesicles
October 2024
Division of Bone & Mineral Diseases, Musculoskeletal Research Center, Washington University School of Medicine, Saint Louis, Missouri, USA.
Adult T cell leukaemia (ATL), caused by infection with human T- lymphotropic virus type 1 (HTLV-1), is often complicated by hypercalcemia and osteolytic lesions. Therefore, we studied the communication between patient-derived ATL cells (ATL-PDX) and HTLV-1 immortalized CD4+ T cell lines (HTLV/T) with osteoclasts and their effects on bone mass in mice. Intratibial inoculation of some HTLV/T leads to a profound local decrease in bone mass similar to marrow-replacing ATL-PDX, despite the fact that few HTLV/T cells persisted in the bone.
View Article and Find Full Text PDFTherapeutic advances for the management of adult T cell leukemia: Where do we stand?
Leuk Res
December 2024
Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut, Lebanon; Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon. Electronic address:
Article Synopsis
- - Adult T cell leukemia (ATL) is a serious blood cancer linked to HTLV-1 virus infection, with four subtypes that have varying effects on treatment response and prognosis.
- - While some subtypes benefit from antiretroviral therapy, others, like acute ATL, are more aggressive with poor outcomes and may become resistant to chemotherapy.
- - Newer treatment approaches, including targeted therapies and potential anti-viral strategies focusing on the Tax protein, show promise in improving ATL management, although allogeneic stem cell transplant remains the only curative option for a limited number of patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!